Gilead Sciences, Inc. GILD reported better-than-expected fourth-quarter results and provided an upbeat guidance for 2025.

GlaxoSmithKline's pitch to shareholders kicked ... 2 billion plus in sales for HIV pre-exposure prophylaxis (PrEP) drug Cabenuva (cabotegravir), hepatitis B virus (HBV) antisense drug GSK3228836 ...

GSK managed to beat analysts’ revenue predictions for the first quarter of the year, despite an 8% decline in turnover pegged back by declines in COVID-19-related products. The group posted £6. ...

The lawsuit claims GlaxoSmithKline replaced Flovent with an identical generic version, hurting patients whose insurance wouldn't cover it and costing taxpayers money. Arizona Attorney General Kris ...

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run. Is there scope for more growth? The content of this article is ...

Teva Pharmaceutical Industries Ltd. ADR-2.66% $19.77B ...

After hours: February 7 at 6:55:00 PM EST Loading Chart for GSK ...

After hours: 7:44:54 p.m. EST ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.